Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
C. Pinto, F. Di Fabio, S. Siena, S. Cascinu, F. L. Rojas Llimpe, C. Ceccarelli, V. Mutri, L. Giannetta, S. Giaquinta, C. Funaioli, R. Berardi, C. Longobardi, E. Piana, A. A. Martoni
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)'. Together they form a unique fingerprint.